Rapid risk assessment: Oseltamivir-resistant influenza A(H1N1)2009 cluster in Australia
Oseltamivir-resistant influenza A Australia has reported a cluster of oseltamivir-resistant influenza A(H1N1)2009 cases in the state of New South Wales. The cases had no known link to oseltamivir exposure and individuals were not immunosuppressed, but they were closely linked geographically. Samples from the cluster do not currently exhibit any resistance to zanamivir.Although the cluster has remained localised, it cannot be assumed that the variant virus will not spread. At present, the risk of this cluster becoming more widespread and having public health implications remains low.However, if spread does occur, implications for the treatment of influenza patients will need to be considered. Regardless of the outcome, constant antiviral resistance monitoring is vital in Europe and globally.Since the A(H1N1)2009 virus antigen is included in the recommended seasonal flu vaccine for the coming season this potential for emergence of oseltamivir resistance is yet another reason why EU citizens, for whom vaccination is recommended by Member States, should accept the offer.
Rapid risk assessment: Multi-country outbreak of Salmonella Enteritidis phage types 56 and 62, MLVA profile 2-11-3-3-2 and 2-12-3-3-2 infections, 20 July 2017
A multi-country outbreak of S. Enteritidis delineated through whole genome sequencing analysis is currently ongoing, with 314 confirmed cases in Austria, France, Ireland, Luxembourg and the United Kingdom.Read more
Influenza A(H7N9) virus in China - implications for public health - 7th update, 3 July 2017
Since the notification of a novel reassortant influenza A(H7N9) virus on 31 March 2013, 1 548 laboratory-confirmed cases of human infection with avian influenza A(H7N9) virus have been reported.Read more